Madrigal Pharmaceuticals, Inc. MDGL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $203.78M+94.0% | $105.02M+5.1% | $99.92M-69.9% | $331.55M+814% | ||
| $784.87M-5.0% | $826.23M+54.7% | $534.22M+1,862% | $27.23M-88.4% | ||
| $388.42M+326% | $91.18M— | —— | $0— | ||
| $262.9M+418% | $50.71M— | $0— | $0— | ||
| $1.25B+20.6% | $1.03B+62.1% | $637.28M+76.4% | $361.37M+33.0% | ||
| $1.5M-31.6% | $2.19M+41.0% | $1.55M+158% | $601K-29.4% | ||
| $7.38M+56.1% | $4.73M— | $0— | —— | ||
| $1.26B+20.9% | $1.04B+62.7% | $640.55M+76.7% | $362.57M+32.6% | ||
| $48.88M+12.1% | $43.6M+55.5% | $28.04M+17.7% | $23.83M+11.5% | ||
| —— | —— | —— | —— | ||
| $310.29M+83.3% | $169.28M+42.8% | $118.55M+2.3% | $115.89M+50.8% | ||
| $339.88M+189% | $117.57M+1.8% | $115.48M+134% | $49.29M— | ||
| $346.61M+192% | $118.59M+1.6% | $116.67M+137% | $49.29M+12,636% | ||
| $656.9M+128% | $287.86M+22.4% | $235.21M+42.4% | $165.18M+114% | ||
| 200M+9,999,900% | 2K0.0% | 2K0.0% | 2K0.0% | ||
| -$2.09B-16.0% | -$1.8B-34.9% | -$1.34B-38.8% | -$962.66M-44.3% | ||
| $602.69M-20.1% | $754.38M+86.1% | $405.33M+105% | $197.39M+0.7% | ||
| $1.26B+20.9% | $1.04B+62.7% | $640.55M+76.7% | $362.57M+32.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Madrigal Pharmaceuticals, Inc.'s total assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) holds $1.2B in total assets, up 23.2% year over year.
- How much debt does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. carries $377.3M in total debt against $543.5M of shareholders' equity, a debt-to-equity ratio of 0.69.
- How much cash does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. holds $232.2M in cash and equivalents.
- Can Madrigal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.50 — current assets exceed current liabilities.
- Where does Madrigal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
